Metraipolis › archive › dc_67cc705ffaaf

Risk of Hypophosphatemia Following Postpartum Anemia Treatment with IV Ferric Carboxymaltose, IV Ferric Derisomaltose, and Oral Ferrous Sulfate — Europe PMC PMID:41375693

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41375693
DOI: 10.3390/jcm14238393
License (as archived): solo-consultazione
Archived: 2026-11-08T05:50:39.243Z
SHA-256 of the archived text: d680802ddbdbc70d699271d1bf08608d061cf5b5a42d7a8d25051df5db634e75
Stable URL of this page: https://metraipolis.com/documento/dc_67cc705ffaaf

How to cite

Risk of Hypophosphatemia Following Postpartum Anemia Treatment with IV Ferric Carboxymaltose, IV Ferric Derisomaltose, and Oral Ferrous Sulfate — Europe PMC PMID:41375693 — Europe PMC (en), https://europepmc.org/article/MED/41375693 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_67cc705ffaaf (Metraipolis archive dc_67cc705ffaaf, sha256 d680802ddbdbc70d699271d1bf08608d061cf5b5a42d7a8d25051df5db634e75)

BibTeX

@misc{dc67cc705ffaaf,
  title = {Risk of Hypophosphatemia Following Postpartum Anemia Treatment with IV Ferric Carboxymaltose, IV Ferric Derisomaltose, and Oral Ferrous Sulfate — Europe PMC PMID:41375693},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41375693},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_67cc705ffaaf; sha256 d680802ddbdbc70d699271d1bf08608d061cf5b5a42d7a8d25051df5db634e75},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41375693. Agents can read the archived copy with the MCP tool read_document.